54064-40-3 Suppliers

Recommended suppliersmore

54064-40-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 54064-40-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,0,6 and 4 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 54064-40:
(7*5)+(6*4)+(5*0)+(4*6)+(3*4)+(2*4)+(1*0)=103
103 % 10 = 3
So 54064-40-3 is a valid CAS Registry Number.

54064-40-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name	Ethyl 5-methyl-2-nitrobenzoate

1.2 Other means of identification

Product number	-
Other names	ethyl 5-methyl-2-nitrophenylcarboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:54064-40-3 SDS

54064-40-3Upstream product

54064-40-3Downstream Products

54064-40-3Relevant articles and documents

Concise syntheses of the novel 1H-pyrrolo[3,2-g]quinazoline ring system and its [2,3-f] angular isomer

Showalter, H. D. Hollis,Sun, Li,Sercel, Anthony D.,Winters, R. Thomas,Denny, William A.,Palmer, Brian D.

, p. 1155 - 1158 (1996)

NOVEL ANTI-INFLAMMATORY AGENTS

-

Page/Page column 80-82, (2010/11/05)

Disclosed are methods of regulating interleukin-6 (IL-6) and/or vascular cell adhesion molecule-1 (VCAM-1) and methods of treating and/or preventing cardiovascular and inflammatory diseases and related disease states, such as, for example, atherosclerosis, asthma, arthritis, cancer, multiple sclerosis, psoriasis, and inflammatory bowel diseases, and autoimmune disease(s) by administering a naturally occurring or synthetic quinazolone derivative. The invention provides novel synthetic quinazolone compounds, as well as pharmaceutical compositions comprising those compounds.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 54064-40-3

CAS

54064-40-3